"I think this is a little bit of an overreaction. Of course, we are all over this," Ford said. "We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, ...
Abbott Laboratories (ABT) is bracing for the impact of higher tariffs, including a 50% US levy on its Indian imports. "Our impact between the whole network is just under $200 million," CEO Robert Ford ...
Abbott Laboratories (NYSE:ABT) on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. First-quarter sales increased 4 ...
Abbott Laboratories CEO Robert Ford unpacked his company's latest quarterly report in a Thursday interview with CNBC's Jim Cramer, saying that Wall Street's reaction to the results was extreme. "I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback